News and announcements

Infratil is holding a briefing for analysts and institutional investors in Sydney from 9am AEST today, featuring the attached presentation from Australasian data centre operator CDC. Infratil CEO Jason Boyes

Infratil Independent Valuation Update – 31 December 2025 Attached is an update on the independent valuations completed for three of Infratil’s portfolio companies as at 31 December 2025. Using the

Attached is a copy of the latest Infratil Newsletter for investors. It includes commentary on progress at various portfolio companies and confirms completion of the sale process for two previously

CDC Independent Valuation – 31 December 2025 CDC’s valuation increased in the quarter, supported by an additional 40MW of previously announced contracted capacity, the addition of 196MW of built operating

Attached is a copy of the latest Infratil Newsletter for investors. It includes commentary on the recent HY26 financial results and the common topics discussed with investors since the results.

Independent valuations were completed for five of Infratil’s portfolio companies as at 30 September. The CDC valuation was previously released on 7 October 2025. The table below show four company

CDC is set to announce a new strategic partnership with Firmus Technologies and NVIDIA today at the NVIDIA AI Day in Sydney. The first stage of the new partnership is

Infratil Newsletter – September 2025 Infratil Investor Day We had a fantastic turnout from institutional investors and analysts at Infratil’s Investor Day in Sydney on 18 September. As Chair Alison

CDC Independent Valuation – 30 September 2025 CDC’s valuation increased in the quarter as it continues to establish itself as a global leader in data centre development and operations, with

CDC has today confirmed it has secured approximately 100MW of new contracted capacity. Infratil CEO Jason Boyes said the announcement underscores strong ongoing demand in the Australasian data centre market.

Infratil portfolio set for growth Confidence in future growth is the feature of Infratil’s Investor Day in Sydney today, as global data centre demand continues to drive the infrastructure investment

Please find attached a copy of presentation materials being used for a North American renewables valuation workshop with analysts this afternoon. An illustrative renewables valuation model to accompany the materials

Infratil Independent Valuation Update - 30 June 2025 A number of Infratil's investments have independent valuations completed as at 30 June, with those results summarised below. The valuations for Longroad Energy, Galileo, Mint Renewables and Qscan below reflect

The One Big Beautiful Bill Act was passed by the United States Congress and signed into law by President Donald Trump on 4 July 2025. The legislation outlines key elements

The 30 June 2025 independent valuation of Infratil’s investment in CDC shows an increase of A$148 million over the three months since the 31 March 2025 valuation. The increase reflects

In this month’s update, we share key takeaways from the Macquarie Australia Conference, assess the implications of the Liberation Day tariffs for our portfolio, update on the Commerce Commission clearance

CDC Well Positioned for Growth, Driven by AI and Hyperscale Demand Last Wednesday (9 April 2025), CDC CEO Greg Boorer and members of his senior management team hosted an investor

CDC management hosted a briefing today as part of a site visit to its new Brooklyn campus in Melbourne, which became operational in 2024. A copy of the presentation from

As a result of the transaction announcement in February, the primary valuation methodology applied by the independent valuer at 31 March 2025 was adjusted from a Discounted Cash Flow (‘DCF’)

Infratil Limited's 31 December 2024 independent valuation update is attached. As noted in the attached, a number of Infratil's investments have independent valuations completed as at 31 December, with those